23 results
ARS
2023 FY
TARS
Tarsus Pharmaceuticals Inc
26 Apr 24
Annual report to shareholders
4:27pm
") and a draft of the labeling and package leaflet, which are sent to the other Member States (referred to as the "Concerned Member States
DEFA14A
TARS
Tarsus Pharmaceuticals Inc
26 Apr 24
Additional proxy soliciting materials
4:25pm
. In order to receive a paper package in time for this year's meeting, you must make this request on or before June 3, 2024. styleINA P.O. BOX 8016
8-K
EX-1.1
TARS
Tarsus Pharmaceuticals Inc
1 Mar 24
Tarsus Announces Proposed $100.0 Million Public Offering
5:26pm
, 2024 or such other time as agreed by the Company and the Representatives.
“General Disclosure Package” means any Issuer General Use Free Writing … the statements therein not misleading. At the Applicable Time, the Closing Time and any Date of Delivery, none of (A) the General Disclosure Package, (B) any
8-K
EX-1.1
wfto u3utmh
2 Aug 23
Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of
4:10pm
ARS
vk1ccfczxp
26 Apr 23
Annual report to shareholders
4:08pm
DEFA14A
bu8oz
26 Apr 23
Additional proxy soliciting materials
4:06pm
CORRESP
wg7cn nfyvxojd
13 Apr 23
Correspondence with SEC
12:00am
8-K
EX-1.1
etbhqt7gfpe
3 May 22
Tarsus Announces Proposed $50 Million Underwritten Public Offering of Shares of its Common Stock
8:34pm
DEFA14A
nhxrxd 5nba3yo5
2 May 22
Additional proxy soliciting materials
6:17am
DEFA14A
r5791gfhkp j16399
30 Apr 21
Additional proxy soliciting materials
4:05pm
10-K
luc2uxyl k0w84lcnqdd
31 Mar 21
Annual report
5:01pm
424B4
pu8msp
16 Oct 20
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-1.1
0pqs52 cmx50c0c6irc
9 Oct 20
IPO registration (amended)
5:16pm
S-1/A
k93qsw
9 Oct 20
IPO registration (amended)
5:16pm